INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 17 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q4 2015. The put-call ratio across all filers is 33.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 12 | -99.9% | 0.00% | – |
| Q3 2017 | $10,000 | -52.4% | 10,018 | +0.1% | 0.00% | – |
| Q2 2017 | $21,000 | -16.0% | 10,012 | 0.0% | 0.00% | – |
| Q1 2017 | $25,000 | +19.0% | 10,012 | 0.0% | 0.00% | – |
| Q3 2016 | $21,000 | +31.2% | 10,012 | 0.0% | 0.00% | – |
| Q2 2016 | $16,000 | -20.0% | 10,012 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | 0.0% | 10,012 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | +11.1% | 10,012 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -37.9% | 10,012 | 0.0% | 0.00% | – |
| Q2 2015 | $29,000 | – | 10,012 | +83333.3% | 0.00% | – |
| Q1 2015 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | – | 12 | 0.0% | 0.00% | – |
| Q1 2014 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST FOUNDATION ADVISORS | 274,592 | $686,000 | 0.04% |
| Argent Trust Co | 39,137 | $98,000 | 0.04% |
| Acrospire Investment Management LLC | 10,777 | $27,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 20,412 | $51,000 | 0.00% |
| HL FINANCIAL SERVICES LLC | 33,000 | $83,000 | 0.00% |
| Advisor Group, Inc. | 30,067 | $75,000 | 0.00% |
| Financial Architects, Inc | 1,100 | $3,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 245,800 | $615,000 | 0.00% |
| DEUTSCHE BANK AG\ | 305,807 | $763,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 16 | $0 | 0.00% |